Author:
Coriat Romain,Sibaud Vincent,Bourgeois Vincent,Manfredi Sylvain,Artru Pascal,Trouilloud Isabelle,Kremliovsky Michael,Arvis Pierre,Palma Mario Di
Subject
Gastroenterology,Hepatology
Reference42 articles.
1. Multikinase inhibitor-induced hand–foot skin reaction: a review of clinical presentation, pathogenesis, and management;Chanprapaph;Am J Clin Dermatology,2016
2. Regorafenib-associated hand–foot skin reaction: practical advice on diagnosis, prevention, and management;McLellan;Ann Oncol,2015
3. European Medicines Agency. Stivarga (regorafenib) Summary of Product Characteristics. 2013.
4. Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial;Grothey;Lancet,2013
5. Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial;Demetri;Lancet,2013